↓ Skip to main content

Working towards a Group A Streptococcal vaccine: Report of a collaborative Trans-Tasman workshop

Overview of attention for article published in Vaccine, May 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Working towards a Group A Streptococcal vaccine: Report of a collaborative Trans-Tasman workshop
Published in
Vaccine, May 2014
DOI 10.1016/j.vaccine.2014.05.017
Pubmed ID
Authors

Nicole J. Moreland, Claire S. Waddington, Deborah A. Williamson, Shiranee Sriskandan, Pierre R. Smeesters, Thomas Proft, Andrew C. Steer, Mark J. Walker, Edward N. Baker, Michael G. Baker, Diana Lennon, Rod Dunbar, Jonathan Carapetis, John D. Fraser

Abstract

Group A Streptococcus (GAS) infections represent a major public health burden in both developing and developed countries. In Australia and New Zealand GAS associated diseases are serious problems in Indigenous populations and a major cause of health inequality. Political recognition of these inequalities is providing impetus for strategies that reduce GAS disease and the development of a GAS vaccine now has governmental support in both Australia and New Zealand. Accordingly, an expert workshop was convened in March 2013 to consider available data on GAS vaccines. M-protein based vaccines constructed from the hyper-variable N-terminal region (30-valent vaccine) or the conserved C-repeat domain (J8 vaccine) were reviewed together with vaccine candidates identified using multi high-throughput approaches. Performing a comprehensive assessment of regional GAS strain epidemiology, defining the immune correlates of protection, and the establishment of clinical trial sites were identified as critical activities for a Trans-Tasman vaccine development programme.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
Brazil 1 2%
Unknown 57 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 18%
Student > Ph. D. Student 10 17%
Student > Bachelor 9 15%
Student > Master 7 12%
Student > Doctoral Student 4 7%
Other 8 13%
Unknown 11 18%
Readers by discipline Count As %
Medicine and Dentistry 17 28%
Agricultural and Biological Sciences 11 18%
Immunology and Microbiology 4 7%
Social Sciences 3 5%
Biochemistry, Genetics and Molecular Biology 3 5%
Other 8 13%
Unknown 14 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2014.
All research outputs
#20,656,820
of 25,374,647 outputs
Outputs from Vaccine
#14,743
of 16,509 outputs
Outputs of similar age
#177,924
of 241,811 outputs
Outputs of similar age from Vaccine
#148
of 171 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,509 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.7. This one is in the 5th percentile – i.e., 5% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,811 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 171 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.